• 1
    Alpert S, Kang H-I, Weissan I et al (1994). Expression of granzyme A in salivary gland biopsies from patients with Sjögren's syndrome. Arthritis Rheum 37: 10461054.
  • 2
    Alspaugh MA, Tan EM (1975). Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 55: 10671073.
  • 3
    Amft N, Bowman SJ (2001). Chemokines and cell trafficking in Sjögren's syndrome. Scand J Immunol 54: 6269.DOI: 10.1046/j.1365-3083.2001.00970.x
  • 4
    Anaya JM, McGuff S, Banks PM et al (1996). Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum 25: 337346.
  • 5
    Aragona P, Magazzu G, Macchia G et al (1999). Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome. J Rheumatol 26: 13061311.
  • 6
    Arnett FC, Bias WB, Reveille JD (1989). Genetic studies in Sjögren's syndrome and systemic lupus erythematosus. J Autoimmun 2: 403413.
  • 7
    Atkinson JC, Fox PC, Travis WD et al (1989). IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome. J Rheumatol 16: 12051210.
  • 8
    Atkinson JC, Travis WD, Slocum L et al (1992). Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome. Arthritis Rheum 35: 13681372.
  • 9
    Bacman S, Perez Leiros C, Sterin-Borda L et al (1998). Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Opthalmol Vis Sci 39: 151156.
  • 10
    Bacman S, Sterin-Borda L, Camusso JJ et al (1996). Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 104: 454459.
  • 11
    Ben-Chetrit E, Chan EK, Sullivan KF et al (1988). A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 167: 15601571.
  • 12
    Beroukas D, Goodfellow R, Hiscock J et al (2002). Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome. Lab Invest 82:203210.
  • 13
    Boire G, Gendron M, Monast N et al (1995). Purification of antigenically intact Ro ribonucleoproteins: biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 100: 489498.
  • 14
    Bolstad AI, Wassmuth R, Haga H-J et al (2001). HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome. J Rheumatol 28: 15541562.
  • 15
    Clark G, Reichlin M, Tomasi TB (1969). Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 102: 117122.
  • 16
    Daniels TE (1984). Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27: 147156.
  • 17
    Daniels TE (1986). Salivary histopathology in diagnosis of Sjögren's syndrome. Scand J Rheumatol 61 (Suppl.):3643.
  • 18
    Daniels TE, Whitcher JP (1994). Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 37: 869877.
  • 19
    Dauphinee M, Tovar Z, Talal N (1988). B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum 31: 642647.
  • 20
    Davidson KS, Kelly CA, Griffiths ID (1999). Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology 38: 245253DOI: 10.1093/rheumatology/38.3.245
  • 21
    Davies ML, Taylor EJ, Gordon C et al (2002). Candidate T cell epitopes of the human La/SSB autonantigen. Arthritis Rheum 46: 209214.
  • 22
    Dawes C (1987). Physiological factors affecting salivary flow rate, oral sugar clearance and the sensation of dry mouth in men. J Dent Res 66: 648653.
  • 23
    De Vita S, Ferraccioli G, Avellini C et al (1996). Widespread clonal B-cell disorder in Sjögren's syndrome predesposing to Helicobacter pylori-related gastric lymphoma. Gastroenterology 110: 19691974.
  • 24
    Diss TC, Wotherspoon AD, Speight PM et al (1995). B-cell monoclonality, Epstein Barr virus and t (14;18) translocations in myoepithelial sialadenitis and low grade MALT lymphoma of the parotid gland. Am J Surg Pathol 19:531536.
  • 25
    Elagib KEE, Borretzen M, Jonsson R et al (1999). Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation. Clin Exp Immunol 117:388394.DOI: 10.1046/j.1365-2249.1999.00963.x
  • 26
    Fei HM, Kang H, Scharf S et al (1991). Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren's syndrome and autoantibody production. J Clin Lab Anal 5: 382391.
  • 27
    Feltkamp TEW, Van Rossum AL (1968). Antibodies to salivary duct cells and other autoantibodies in patients with Sjögren's syndrome and other idiopathic autoimmune diseases. Clin Exp Immunol 3: 116.
  • 28
    Figura N, Giordiano N, Burroni D et al (1994). Sjögren's syndrome and Helicobacter pylori Infection. Eur J Gastroenterol Hepatol 6: 321322.
  • 29
    Font J, Ramos-Casals M, Cervera R et al (1998). Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance. Br J Rheumatol 37: 12871291.
  • 30
    Fox RI (1992). Treatment of the patient with Sjögren's syndrome. Rheum Dis. Clin North Am 18: 699709.
  • 31
    Fox RI, Chen P, Carson DA et al (1986a). Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjögren's syndrome. J Immunol 136: 477483.
  • 32
    Fox PC, Datiles M, Atkinson JC et al (1993). Prednisone and piroxicam for treatment of primary Sjögren's syndrome. Clin Exp Rheumatol 11: 149156.
  • 33
    Fox RI, Guarrasi V, Krubel S (1996). Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 5 (Suppl. 1):S31S36.
  • 34
    Fox RI, Robinson CA, Curd JC et al (1986b). Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 29: 577585.
  • 35
    Freist E, Kuckelkorn U, Dorner T et al (1999). Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the α and β type. Arthritis Rheum 42: 697702.
  • 36
    Garsia-Carrasco M, Ramos M, Cervera R et al (1997). Hepatitis C virus infection in primary Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 56: 173175.
  • 37
    Gerli R, Muscat C, Giansanti M et al (1997). Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome. Br J Rheumatol 36: 969975.
  • 38
    Goldblatt F, Beroukas D, Gillis D et al (2000). Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms. J Rheumatol 27: 23822388.
  • 39
    Gordon T, Mavrangelos C, McCluskey J (1992). Restricted epitope recognition by precipitin-negative anti-La/SS-B-positive sera. Arthritis Rheum 35: 663666.
  • 40
    Haaheim LR, Halse A-K, Kvakestad R et al (1996). Serum antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La (SS-B) autoantigen resembling viral protein sequences. Scand J Immunol 43: 115121.
  • 41
    Haddad J, Deny P, Munz-Gotheil C et al (1992). Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339: 321323.
  • 42
    Håkansson U, Jacobsson L, Lilja B et al (1994). Salivary gland scintigraphy in subjects with and without symptoms of dry mouth/or eyes, and in patients with primary Sjögren's syndrome. Scand J Rheumatol 23: 326333.
  • 43
    Halse A-K, Wahren M, Jonsson R (1996). Peripheral blood in Sjögren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinant Ro/SSA 52 kD and La/SSB 48 kD autoantigens. Autoimmunity 23: 2534.
  • 44
    Halse A-K, Harley JB, Kroneld U et al (1999a). Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome. Clin Exp Immunol 115: 203207.
  • 45
    Halse A-K, Tengnér P, Wahren-Herlenius M et al (1999b). Increased frequency of IL-6 and IL-10 secreting cells in peripheral blood from patients with primary Sjögren's syndrome. Scand J Immunol 49: 533538.
  • 46
    Halse A-K, Wahren-Herlenius M, Marthinussen MC et al (2000). Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome. Scand J Rheumatol 29: 1319.
  • 47
    Hamilton RG, Harley JB, Bias WB et al (1988). Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 31: 496505.
  • 48
    Haneji N, Nakamura T, Takio K et al (1997). Identification of a – fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 276: 604607.
  • 49
    Harley JB (1989). Autoantibodies in Sjögren's syndrome. J Autoimmun 2: 283294.
  • 50
    Harley JB, Reichlin M, Arnett FC et al (1986). Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 232: 11451147.
  • 51
    Harris NL (1999). Lymphoid proliferations of the salivary glands. Am J Clin Pathol 111 (Suppl. 1):S94S103.
  • 52
    Hauschild S, Schmitt WH, Csernok E et al (1993). ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 336: 245251.
  • 53
    His ED, Siddique J, Schnitzer B et al (1996). Analysis of immunoglobulin heavy chain gene arrangement in myoepithelial sialadenitis by polymerase chain reaction. Am J Clin Pathol 106: 498503.
  • 54
    Horsfall AC, Rose LM, Maini RN (1989). Autoantibody synthesis in salivary glands of Sjögren's syndrome patients. J Autoimmun 2: 559568.
  • 55
    Humphreys-Beher MG, Brayer J, Yamachika S et al (1999). An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiscence rather than destructive autoaggression. Scand J Immunol 49: 710.
  • 56
    Hyjek E, Smith WJ, Isaacson PG (1988). Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 19: 766776.
  • 57
    Ihrler S, Zietz C, Sendelhofert A et al (1999). Lymphoepithelial duct lesions in Sjögren-type sialadenitis. Virchows Arch 434: 315323.
  • 58
    Inagak Y, Jinno-Yoshida Y, Hamasaki Y et al (1991). A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Dermatol Sci 2: 147154.
  • 59
    Isaacson PG, Spencer J (1987). Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11:445462.
  • 60
    James JA, Harley JB, Scofield RH (2001). Role of viruses in systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 13: 370376.
  • 61
    Johansson CM, Nakken B, Sundler M et al (2002). Genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. Eur J Immunol 32: 243250.DOI: 10.1002/1521-4141(200201)32:1<243::aid-immu243>;2-x
  • 62
    Jonsson R (2002). Sjögren's syndrome. In: Dieppe P, Wollheim FA, Schumacher HR, eds. Classic Papers in Rheumatology. Martin Dunitz Ltd.: London, pp. 202–221.
  • 63
    Jonsson R, Klareskog L, Bäckman K et al (1987). Expression of HLA-D locus (DP, DQ, DR) coded antigens, β2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome. Clin Immunol Immunopathol 45: 235243.
  • 64
    Jonsson R, Kroneld U, Bäckman K et al (1993). Progression of sialoadenitis in Sjögren's syndrome. Br J Rheum 32:578581.
  • 65
    Jonsson R, Haga H-J, Gordon T (2001). Sjögren's syndrome. In: Koopman WJ, ed. Arthritis and Allied Conditions – a Textbook of Rheumatology, 14th edn. Lippincott Williams & Wilkins: Philadelphia, pp. 1736–1759.
  • 66
    Jonsson R, Skarstein K (2001). Experimental models of Sjögren's syndrome. In: Theofilopoulos A, Bona C, eds. The Molecular Pathology of Autoimmune Diseases, 2nd edn. Harwood Academic Publishers: Chur, pp. 437–452.
  • 67
    Jordan R, Diss TC, Lench NJ et al (1995). Immunoglobulin gene rearrangements in lymphoplasmyctic infiltrates of labial salivary glands in Sjögren's syndrome: a possible predictor of lymphoma development. Oral Surg Oral Med Oral Pathol 79: 723729.
  • 68
    Kalk WW, Vissink A, Spijkervet FK et al (2001). Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 60: 11101116.
  • 69
    Kalk WW, Vissink A, Stengenga B et al (2002). Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome. Ann Rheum Dis 61: 137144.
  • 70
    Kang HI, Fei HM, Saito I et al (1993). Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J Immunol 150: 36153623.
  • 71
    Kausman D, Allen M, Snaith ML et al (1994). Autoimmunity and the clinical spectrum of Sjögren's syndrome. In: Isenberg DA, Horsfall A, eds. The Molecular Basis of Autoimmunity: Focus on Sjögren's Syndrome. Bios Publishers: Oxford, pp. 1–24.
  • 72
    Keech CL, McCluskey J, Gordon TP (1996). SS-B (La) autoantibodies. In: Peter JB, Schoenfeld Y, eds. Autoantibodies. Elsevier: Amsterdam, pp. 789–797.
  • 73
    Kelly CA, Foster H, Pal B et al (1991). Primary Sjögren's syndrome in northeast England – a longitudinal study. Br J Rheumatol 30: 437442.
  • 74
    Kerttula TO, Collin P, Polvi A et al (1996). Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alterations in circulating T cell receptor gamma/delta subsets. Arthritis Rheum 39: 7331739.
  • 75
    Kino-Ohsaki J, Nishimori I, Morita M et al (1996). Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Gastroenterology 10: 15791586.
  • 76
    Kong L, Ogawa N, Nakabayashi T et al (1997). Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 40: 8797.
  • 77
    Kroneld U, Jonsson R, Carlsten H et al (1998). Expression of the mucosal lymphocyte integrin αEβ7 and its ligand E-cadherin in salivary glands of patients with Sjögren's syndrome. Scand J Rheumatol 27: 215218.
  • 78
    Kruize AA, Henè RJ, Kallenberg CGM et al (1993). Hydroxychloroquine treatment for primary Sjögren's syndrome: a two-year double blind crossover trial. Ann Rheum Dis 52: 360364.
  • 79
    MacSween RNM, Govidie RB, Anderson JR et al (1967). Occurrence of antibody to salivary duct epithelium in Sjögren's disease, rheumatoid arthritis and other arthritides – a clinical and laboratory study. Ann Rheum Dis 26: 402411.
  • 80
    Manoussakis MN, Dimitriou ID, Kapsogeorgou EK et al (1999). Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum 42: 229239.
  • 81
    Manthorpe R, Morling N, Platz P et al (1981). HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form. Scand J Rheumatol 10: 124128.
  • 82
    Manthorpe R, Permin H, Tage-Jensen U (1979). Auto-antibodies in Sjögren's syndrome. With special reference to liver-cell membrane antibody (LMA). Scand J Rheumatol 8: 168172.
  • 83
    Markusse HM, Otten HG, Vroom TM et al (1993). Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 66: 2632.DOI: 10.1006/clin.1993.1004
  • 84
    Martens PB, Pillemer SR, Jacobsson LTH et al (1999). Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976–1992. J Rheumatol 26: 12961300.
  • 85
    Miyagawa S, Shinohara K, Nakajima M et al (1998). Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A- La/SS-B among Japanese subjects. Arthritis Rheum 41: 927934.
  • 86
    Morrow J, Nelson L, Watts R et al (1999). Sjögren's syndrome. In: Morrow J, Nelson L, Watts R, Isenberg D. eds. Autoimmune Rheumatic Disease. Oxford University Press: Oxford, pp. 147–169.
  • 87
    Moutsopoulos HM, Manoussakis MN (1989). Immunopathogenesis of Sjögren's syndrome: facts and fancy. Autoimmunity 5: 1724.
  • 88
    Nakamura H, Koji T, Tominaga M et al (1998). Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I) -seronegative and – seropositive SS patients. Clin Exp Immunol 114: 106112.DOI: 10.1046/j.1365-2249.1998.00692.x
  • 89
    Nakken B, Jonsson R, Brokstad K et al (2001). Associations of MHC class II alleles in Norwegian primary Sjögren's syndrome patients: Implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol 54: 428433.
  • 90
    Nepom GT (1993). MHC and autoimmune diseases. Immunol Rev 59: 143164.
  • 91
    Niemelä RK, Pääkkö E, Suramo I et al (2001). Magnetic resonance imaging and magnetic resonance sialography of parotid glands in primary Sjögren's syndrome. Arthritis Rheum (Arth Care Res) 45: 512518.
  • 92
    Ninomiya T, Iga Y, Fukui K et al (1998). The pharmacological profile of cevimeline: a novel muscarinic agonist for treatment in various models. Arthritis Rheum 41 (Suppl.):S329S329.
  • 93
    Nusair S, Rubinow A (1999). The use of oral pilocarpine in xerostomia and Sjögren's syndrome. Sem Arthritis Rheum 6: 360367.
  • 94
    Ohlsson M, Jonsson R, Brokstad K (2002). Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol 55: 503506.
  • 95
    Ohlsson M, Skarstein K, Bolstad AI et al (2001). Fas-induced apoptosis is a rare event in Sjögren's syndrome, Lab Invest 81: 95105.
  • 96
    Ono M, Ono M, Watanabe K et al (1999). A study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases. J Dermatol Sci 21: 183186.
  • 97
    Oxholm P, Prause JU, Schiødt M (1992). Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome. Drugs 56: 345353.
  • 98
    Papasteriades CA, Skopouli FN, Drosos AA et al (1988). HLA–alloantigen associations in Greek patients with Sjögren's syndrome. J Autoimmun 1: 8590.
  • 99
    Parsonnet J, Hansen S, Rodriguez L et al (1994). Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 12671271.
  • 100
    Pease CT, Charles PJ, Shattles W et al (1993). Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome. Br J Rheumatol 32: 574577.
  • 101
    Quintana PG, Kapadia SB, Bahler SW et al (1997). Salivary gland lymphoid infiltrates associated with lymphoepithelial lesions: a clinicopathologic, immunphenotypic, and genotypic study. Hum Pathol 28: 850861.
  • 102
    Reichlin M, Scofield RH (1996). SS-A (Ro) autoantibodies. In: Peter JB, Schoenfeld Y, eds. Autoantibodies. Elsevier: Amsterdam, pp. 783–788.
  • 103
    Reveille JD (1992). The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 4: 644656.
  • 104
    Reveille JD, Wilson RW, Provost TT et al (1984). Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med 101: 748756.
  • 105
    Rischmueller M, Lester S, Chen Z et al (1998). HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin Exp Immunol 111: 365371.DOI: 10.1046/j.1365-2249.1998.00504.x
  • 106
    Robinson CP, Brayer J, Yamachika S et al (1998a). Transfer of human serum IgG to NOD. Igμnull mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci (USA) 95: 75387543.
  • 107
    Robinson CP, Yamachika S, Bounous DI et al (1998b). A novel NOD-derived murine model for primary Sjögren's syndrome. Arthritis Rheum 41: 150156.
  • 108
    Salomonsson S, Larsson P, Tengnér P et al (2002). Expression of the B cell attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 55: 336342.
  • 109
    Shiozawa S, Morimoto I, Tanaka Y et al (1993). A preliminary study on interferon- alpha treatment for xerostomia of Sjögren's syndrome. Br J Rheumatol 32: 5254.
  • 110
    Ship JA, Fox PC, Michalek JE et al (1999). Treatment of primary Sjögren's syndrome with low-dose natural interferon-α administered by the oral mucosal route: a phase II clinical trial. J Interfer Cytokine Res 19: 943951.
  • 111
    Showji Y, Nozawa R, Sato K et al (1996). Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol 40: 499503.
  • 112
    Silman AJ, Rooney BK (1999). Epidemiology of Sjögren's syndrome In: Eriksson P, Jonsson R, eds. The 100-year Anniversary of Henrik Sjögren. Hygiea, 108: pp 53–57. ISBN: 91-630-8381-7; ISSN: 03491722.
  • 113
    Sjögren H (1933). Zur kenntnis der keratoconjunctivitis sicca. Acta Opthalmol 11 (Suppl. II):1151.
  • 114
    Skarstein K, Nerland AH, Eidsheim M et al (1997). Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis. Scand J Immunol 46: 373378.
  • 115
    St. Clair EW, Kenan D, Burch JA et al (1991). Anti-La antibody production by MRL- lpr/lpr mice: analysis of fine specificity. J Immunol 146: 18851892.
  • 116
    Sumida T, Yonaha F, Maeda T et al (1992). T-cell receptor repertoire of infiltrating T-cells in lips of Sjögren's syndrome patients. J Clin Invest 89: 681685.
  • 117
    Sutcliffe N, Inanc M, Speight et al (1998). Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 28: 8087.
  • 118
    Tengnér P, Halse A-K, Haga H-J et al (1998). Detection of anti-Ro/SSA and anti- La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 41: 22382248.
  • 119
    Theander E, Nilsson I, Manthorpe R et al (2001). Seroprevalence of Helicobacter pylori in primary Sjögren's syndrome. Clin Exp Rheumatol 19: 633638.
  • 120
    Tishler M, Yaron I, Shirazi I et al (1997). Saliva: an additional diagnostic tool in Sjögren's syndrome. Semin Arthritis Rheum 27: 173179.
  • 121
    Tzioufas AG, Manoussakis MN, Costello R et al (1986). Cryoglobulinaemia in autoimmune rheumatic diseases. Arthritis Rheum 29: 10981104.
  • 122
    Tzioufas AG, Bouma DS, Skopouli FN et al (1996). Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive epitopes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 39: 767772.
  • 123
    Tzioufas AG, Moutsopoulus HM (1994).Sjögrens's syndrome: from polyclonal B cell activation to monoclonal B cell proliferation. In: Panayi GS, Whaley K, eds. Immunology of Connective Tissue Diseases. Kluwer Academic Publishers: Dordrecht, pp. 335–354.
  • 124
    Venables PJ, Shattles W, Pease CT et al (1989). Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome. Clin Exp Rheumatol 7: 181184.
  • 125
    Vitali C, Bombardieri S, Jonsson R et al (2002). Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European consensus group. Ann Rheum Dis (in press).
  • 126
    Vitali C, Bombardieri S, Moutsopoulos H et al (1993). Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36: 340347.
  • 127
    Vitali C, Moutsopoulos HM, Bombardieri S et al (1994). The European community study group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 53: 637647.
  • 128
    Voulgarelis M, Dafni UG, Isenberg DA et al (1999). Malignant lymphoma in primary Sjögren's syndrome – a multicenter, retrospective, clinical study by the European concerted action on Sjögren's syndrome. Arthritis Rheum 42: 17651772.
  • 129
    Wahren M, Skarstein K, Blange I et al (1994). MRL/lpr mice produce anti-Ro 52kD antibodies – detection, analysis of specificity and site of production. Immunology 83: 915.
  • 130
    Watanabe T, Tsuchida T, Kanda N et al (1999). Anti-alpha-fodrin antibodies in Sjögren's syndrome and lupus erythematosus. Arch Dermatol 135: 535539.
  • 131
    Waterman SA, Gordon TP, Rischmueller M (2000). Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 43: 16471654.
  • 132
    Xanthou G, Polihronis M, Tzioufas AG et al (2001). `Lymphoid' chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients. Arthritis Rheum 44: 408418.